The increased prevalence of chronic wounds requires novel treatment options. The aim of this study was to develop a beta-glucan (βG)-loaded nanofiber wound dressing. Nanofibers were prepared using the needle-free Nanospider™ technology, an electrospinning method which enables the production of nanofibers at an industrial scale. The βG was selected as active ingredient based on its confirmed wound healing potential in both animals and humans. Hydroxypropyl methylcellulose (HPMC) and polyethylene oxide (PEO) were included as copolymers. Rheological profiles of spinning solutions containing HPMC, PEO, βG, ethanol and water, were optimized. The nanofiber formation was confirmed by Field Emission Scanning Electron Microscopy (FE-SEM), and both nanofibers with (βG-nanofibers) or without βG (NoβG-nanofibers) were evaluated by their swelling index and FT-IR spectroscopy. The formulations, active ingredient and excipients were tested for their possible in vitro toxicity in keratinocytes. Finally, the wound healing potential of the nanofibers was tested in externally induced excisional wounds in male diabetic db/db mice. Three different doses of βG-nanofibers and the βG-free, NoβG-nanofibers, were evaluated for their in vivo wound healing efficacy. All nanofiber-treatments provided improved wound healing as compared to the negative control (water). All βG-nanofiber treated groups exhibited significantly improved wound healing as compared to the NoβG-nanofiber treated group, indicating the potential of βG-nanofibers as wound dressing.
Introduction
With an aging population and increased prevalence of impaired/ chronic wounds, the search for optimal wound dressings has been intensified in the past years (Han and Ceilley, 2017) . The optimal wound dressing should not only accelerate the wound healing process but also minimize the pain associated with wound healing and dressing change (Woo et al., 2008) . To develop a superior wound dressing, it is crucial to understand the complexity of the skin repair processes involving many different cell types, the role of signals molecules and feedback loops orchestrating the cellular response (Boateng et al., 2008; Frykberg and Banks, 2015; Sorg et al., 2017) . Delayed/impaired wound healing might be caused by different underlying pathologies, such as co-morbidities and peripheral vascular disease and biofilm formation (Percival et al., 2015; Sorg et al., 2017) . Considering the challenges in wound treatment and related health cost (Powers et al., 2016) , pharmaceutical and biotechnological industries, as well as academia, focus more on developing advanced and active wound dressings to replace the nonactive convential wound dressings (Boateng and Catanzano, 2015) .
Among emerging technologies in wound dressing development, nanofibers have gained an increased attention. The nanofibers closely resemble the native extracellular matrix, and, formed as fiber mats, offer improved physical and mechanical wound protection, even against bacterial invasions (Wang and Windbergs, 2017) . Moreover, the fibers permit gas exchange, facilitating the wound healing process. Drugs and various active substances can be incorporated within the fiber mats (Mei et al., 2017 (Mei et al., , 2016 . The drug release of nanofiber-associated drugs can be modified and controlled by the optimization of the spinning conditions (Choi et al., 2015; , as well as by combining this technology with nanocarriers (Mei et al., 2016) .
Considering that the drug release profile has a substantial effect on the wound healing (Wang et al., 2015) , wound healing might be optimized applying this technology. Electrospinning is the most widely used nanofiber fabrication technique (Thakkar and Misra, 2017) , as it offers high flexibility in production and enables controllable nanofiber pore structure from a wide variety of synthetic and natural polymers (Liu et al., 2017) . However, clinical application and practical utilization of the electrospinning technology have so far rarely been reported (Mei et al., 2016) , and in most studies only in vitro tests were included.
Among various active substances with beneficial effects on wound healing, we have focused on β-glucans (βG). They are known to reactivate/activate the innate immune system by binding to the dectin-1 receptor on macrophages, dendritic cells and neutrophils (Ma and Underhill, 2013) . This activation can help to revert immunosuppressed macrophages into a responsive phenotype , and thus improve the stalled wound healing. A formulation containing βG is currently on the market as a hydrogel for treatment of dry chronic wounds (Cutting, 2017; King et al., 2017) . The soluble 2.5% (w/v) βG used in this formulation, as well as in this current study, is a β-1,3/1,6 glucan isolated from cell walls of Baker's yeast (Saccharomyces cerevisiae), and further processed by a patented solubilizing procedure (Engstad and Nøkland, 2017) . This soluble βG forms a gel at room temperature, and has, in previous studies, been confirmed to maintain its immune-stimulating activity both in human cell-lines and animal models (Engstad et al., 2002; Engstad and Robertsen, 1994) , as well as wound healing capability in chronic wounds (Zykova et al., 2014) .
βG represents a heterogeneous group of glucose polymers differing in size and branching, depending on both the source from where βG was isolated (i.e. yeast, fungi, bacteria, and cereal), and the processing methods applied in the isolation and purification processes (Zhu et al., 2016) . In previous reports on the successful electrospinning of βG (Basha et al., 2017; Kawahara, 2014; Kim et al., 2012; Woo et al., 2010) , the βG raw material applied, both regarding the source and processing method, differed from the one used in our study. Moreover, in those studies, relatively little focus has been paid to the optimization and utilization of the electrospinning technology used to manufacture the wound dressing; and only Kim and coworkers (Kim et al., 2012) included in vivo wound healing investigations in their study. The main aim of this study was to develop an active nanofiber dressing, which could be clinically relevant and effective in the treatment of medium exuding chronic wounds. Moreover, we targeted a nanofiber production method applicable in an industrial scale manufacturing. For these reasons, the needle-free Nanospider™ spinning technology, developed by Elmarco (Liberec, Czech Republic), was selected. This technology enables a 26-80 times faster production of nanofibers than the traditional single needle electrospinning setup, even when using the smallest Nanospider™ Lab machine, with a production speed of around 40 mL/h (Stepanyan et al., 2016; Zhang et al., 2015) . We selected hydroxypropyl methyl cellulose (HPMC) as a copolymer since cellulose derivatives are known to form homogenous nanofiber mats of uniform quality (Frenot et al., 2007) ; and polyethylene oxide (PEO) was added to assure fiber formation. The choice of production method as well as the pharmaceutical ingredients used represent a novel approach in spinning of βG. Finally, both the βG-loaded and βG-free nanofibers were optimized and evaluated in the chronic wound model, diabetic db/db mice.
Materials and methods

Materials
Milli-Q water was produced using the Q-Pod® by Merck Millipore (Billerica, MA, USA). Sodium chloride and calcium chloride was purchased from Merck (Kenilworth, USA). Soluble beta-1,3/1,6-glucan (βG; 2.5% w/w) was a gift from Biotec BetaGlucans AS (Tromsø, Norway). The two types of hydroxypropyl methylcellulose (HPMC) used in this study, Metolose 60SH-4000 (Hypromellose 2910) and Metolose 90SH-4000 (Hypromellose 2208), were generous gifts from HARKE Pharma GmbH (Mülheim an der Ruhr, Germany). Polyethylene oxide (PEO) was obtained from Sigma-Aldrich (Taufkirchen, Germany). Ethanol (EtOH, 96% v/v) was purchased from Kemetyl (Kolbotn, Norway).
Polymer solution preparation and characterization
Five different polymer spinning solutions were prepared (Table 1) . Two solutions were applied in the production of the final electrospun nanofibers and used in the in vivo studies (βG-Sol and NoβG-Sol), and the three other solutions were considered the reference solutions (RefSol 1, 2 and 3). All Ref-Sol were prepared as described by Frenot et al. (2007) , who successfully produced HPMC fibers from similar solutions using the traditional needle electrospinning setup. Two different HPMC qualities were tested (HPMC1 and HMPC2), and their specifications are given in Table 2 together with the properties of the other polymers applied in the formulations, namely PEO and βG. The solvents applied were EtOH alone (NoβG-Sol) or EtOH in combination with water (βG-Sol, . PEO, HPMC and βG were mixed from pre-made solutions. The PEO solution (5%, w/w) was prepared in EtOH (96%) and heated at 70°C under constant stirring for 30 min, before cooling to room temperature (Ho et al., 2006) . The HPMC1 ethanolic solution, premade for the βG-Sol and NoβG-Sol, had a final HPMC concentration of 2.91% (w/w), and was prepared at room temperature, whereas the premade HPMC solutions made for the Ref-Sols, containing either HPMC1 or HMPC2, were made from EtOH: water (50/ 50, v/v) solvent blends. The βG-Sol was prepared by heating the gelled βG (2.5%, w/w) to 60°C. Heating was conducted to break up aggregates and convert the gel into the liquid form. The HPMC-Sol, PEOSol and βG-Sol were mixed to reach the final polymer compositions of the spinning solutions, as listed in Table 1 .
The viscosities of the electrospinning solutions were measured and compared using a Discovery HR-2 Hybrid Rheometer (TA Instruments, New Castle, DE, USA) equipped with 40 mm crosshatched plate geometry. The crosshatched plate was lower to form a gap of 1050 μm against the platform, excess solution removed and the plate lowered to operational height of 1000 μm. The samples were soaked for 120 s at 25°C to provide a stable temperature during the measurement. The flow sweep protocol was performed as a logarithmic sweep from 10 to 1000 Pa, logging 10 point per decade using a steady state sensing. The results were processed by the Trios software v. 3.2.0.3877 (TA Instruments, New Castle, DE, USA) to determine the flow characteristics using the viscosity as a function of the shear rate.
Electrospinning
The Elmarco Nanospider™ Lab electrospinning machine (Liberec, Czech Republic), with a roll-to-roll collection unit and an adjustable substrate speed of between 0 and 5000 mm/min, and a spinning electrode wire with a power supply capable of delivering 80 kV DC current, Table 2 . b The water content in βG-Sol originates from the 2.5% (w/w) βG.
was applied. The ambient room temperature was kept at 26 ± 1°C, with a relative humidity of 35 ± 2%. The distance from the electrode to the collector was 20 cm, and the maximum voltage of 80 kV was chosen. The polymer solution carriage reservoir, feeding the electrode with the polymer solution, was set to move at max speed, corresponding to 300 mm/s; the substrate setting applied was 2-4 mm/min, depending on the targeted thickness (weight/area) of the nanofiber.
Fourier-Transform Infrared Spectroscopy (FTIR) analysis
The dry polymer materials included in the electrospun nanofibers (PEO, HMPC, and freeze dried βG), and the final electrospun nanofibers (βG-and NoβG-nanofibers) were analyzed on a Cary 630 FTIR instrument from Agilent Technologies (Santa Clara, CA, USA); equipped with a diamond ATR sampling accessory. All FTIR spectra were acquired in 64 scans.
Field Emission Scanning Electron Microscopy (FE-SEM) analysis
The morphology of the electrospun fibers was investigated by Field Emission Scanning Electron Microscopy (FE-SEM), applying the Zeiss Sigma FE-SEM (Carl Zeiss, Oberkochen, Germany). The samples were put on stubs with double sided carbon tape and two drops of conductive silver paint (Agar Scientific, Essex, UK) added to increase conductivity. The samples were dried for 24 h under an incandescent lamp, before they were sputter-coated with gold/palladium using a Polaron SC7640 (Quorum Technologies LTD, Kent, UK). Micrographs were taken from the middle of the product roll, to assure a representative sample for imaging.
Swelling index determination
The absorption capacity of the two types of nanofibers applied in the animal study were investigated using a modified method by Boateng et al. (2013) . The absorption fluid used in testing was the "Solution A" from the ISO standard EN 13726-1 (Standard, 2002) which simulates the ions concentration in human wound exudate (142 mmol Na + , 2.5 mmol Ca 2+ ). The fiber mats were cut into 8 × 8 cm pieces.
The dry fibers were placed in 140 mm ø Petri dishes (VWR, Norway), weighed (W d ), and then submerged in "Solution A" for 1 min (Sup. Fig. 1 ). The excess liquid was immediately removed and the Petri dish left at a 90°angle to drain liquid from the fibers for 1 min. The excess liquid was removed using tissue paper before the weight of the wet fiber mats (W s ) was determined. The experiment was done in triplicates and the swelling index I s (%) was calculated using Eq. (1).
W d = Weight of dry film. W s = Weight of film after swelling.
Cytotoxicity of electrospun nanofibers
The in vitro toxicity of the electrospun nanofibers was evaluated on keratinocytes (HaCaT cells) supplied from Thermo Fisher Scientific (Waltham, USA). Cells were cultured in RPMI medium (Sigma Aldrich, Steinheim, Germany) supplemented with glutamine and 10% fetal calf serum (FCS) at humidified 5% CO 2 and 37°C. The toxicity of the electrospun nanofibers was tested by the MTT assay using the cell proliferation kits from Roche (Sigma Aldrich) according to the instruction provided by the supplier. In brief, 90 μL of trypsinized HaCaT cells were plated in the flat bottom 96 wells plate as the cell concentration 5 × 10 5 cells/mL. To each well 10 μL media only (control) or the samples diluted in media (resulting in a final concentrations of 1, 10 or 100 μg/mL, respectively) were added. The cells were incubated for 24 h at humidified 5% CO 2 and 37°C. The next day, 10 μL of MTT (final concentration of 0.5 mg/mL) was added to each well and the cells incubated for 4 h for the development of violet crystals of formazon. After 4 h, 100 μL of solubilizing reagents (supplied in the assay kits) was added to each well and the cells were kept in the humidified incubator for 24 h. The UV absorption of soluble formazon was determined on ELISA plate reader at 580 nm. The UV absorption determined for the control group was considered as 100% viable and the effects of various concentrations of tested samples on cell toxicity were expressed as percentage viability as compared to the control. Results are expressed as the mean of two independent experiments for each sample.
Effect of nanofibers on wound healing in diabetic mice
2.8.1. Animal study setup The in vivo evaluation of wound healing potential of nanofibers was carried out following the protocol previously described by our group (Grip et al., 2017) . The study was conducted in accordance to the Home Office Regulations UK and the specific requirements of diabetic animals (Home Office, 2014). Male diabetic db/db mice (BKS.Cg-m Dock7m +/+ Leprdb/J mice), 9-10 weeks old (weight 45.6 ± 2.6 g) provided by Jackson Labs (Bar Harbour, ME, USA) were randomly divided into six experimental groups (10 mice per group); four groups were treated with nanofibers and two groups received the positive and negative control, respectively. Three different doses of βG-nanofibers and NoβG-nanofibers (vehicle control) were tested ( Table 3 ). The treatment was applied on day 0, 4 and 8 in the nanofiber treated groups, and on day 0, 2, 4, 6 and 8 for the animals receiving negative control, and on day 0, 1, 2, 3, 4, 5 and 6 for the animals treated with positive controls (more details are given in supplement; Sup. Table 1 ).
Wound induction and treatment
The wounds were induced on day 0. All animals were anaesthetized using 4% isoflurane (IsoFlo®, purchased from Zoetis (London, UK)) and 96%, air followed by 2% isoflurane and 98% (v/v) air for maintenance. Their left dorsal flank was shaved and cleaned, and a single standardized full-thickness wound (1 × 1 cm) created approximately 10 mm from the spine. The wounds were covered with a polyurethane 
Table 3
The doses of βG-nanofibers applied in the in vivo study on diabetic db/db mice wound model. occlusive film (Bioclusive® film, purchased from Systagenix Wound Management (Gargrave, UK)). Water for injection (50 μL) was injected under the occlusion film of the animals in the negative control group. In the positive control group, mice received 50 μL solution containing growth factors; 10 μg/dose platelet-derived growth factor-BB and 1 μg/ dose transforming growth factor-alpha (both purchased from PeproTech EC Ltd., London, UK) dissolved in 0.5% (w/v) HPMC. For the nanofiber-treated animals the occlusive film was applied over the nanofibers after they were placed onto the wound forming a hydrogel (in situ), as shown in Fig. 1 . The nanofiber mats were cut in 1 × 1 cm slices except for the group treated with HighβG nanofibers; these nanofibers were cut in 1 × 3 cm and folded twice to form three layers (same contact area). All animals received 75 μg/kg Vetergesic® (purchased from Alstoe Animal Health (Espoo, Finland)) post-surgery -dose volume 100 μL. When necessary, the Vetergesic® treatment was repeated every 12 h.
Wound closure assessment
Image Pro Plus image analysis software (version 4.1.0.0, Media Cybernetics, Rockville, MD, USA) was used to measure the size of the wounds by analyzing the images taken at each assessment point (day 0, 4, 8, 12, 16, 20 and 24) . The measurements were made blinded to treatment. To evaluate the changes in the wounds over time, three different parameters were determined from the images as described earlier (Grip et al., 2017) : the (1) open wound area, (2) wound contraction area and (3) re-epithelization area (Sup. Fig. 1 ). Calculations of the three parameters are shown below.
(1). Open wound area:
(2) Wound contraction:
GT GT 0 A 0 = Wound area at Day 0. A GT = Wound area at given time. R GT = Re-epithelialization area at given time. C GT = Wound contraction area at given time.
Histological evaluation
On day 24 post wounding, wound tissue, together with surrounding normal skin were harvested. Samples from all the wounds were fixed in a formaldehyde-buffered solution (10% Neutral Buffered Formalin, Sigma), and embedded in paraffin wax. A representative section (6 μm tick) from each treatment group was stained with Hematoxylin and Eosin (H&E) and the collagen-specific stain Picrosirius Red (Junqueira et al., 1979) ; after which sections were digitally scanned using an Aperio AT2 whole slide scanner (Leica Biosystems, Germany). Digital scans (x20 equivalent magnification) were viewed using Aperio Imagescope software (version 12.3.0.5056, Leica Biosystems, Germany) and investigated to assess the impact of the various treatment regimens on the progression of wound healing. The healing was assessed in terms of the extent of granulation tissue formation, collagen deposition within granulation tissue and re-epithelialization.
Statistical analysis
A two tailed t-test was used to determine the difference between the swelling index I s (%) of nanofibers. A p values of < 0.05 was considered the significant difference between the formulations.
The two-sample non-parametric statistical Mann-Whitney U test was used to determine statistically significant differences in wound healing between groups in the animal study. Significant difference between the groups was set to p < 0.05.
Results and discussion
The ideal wound dressing should, in general, be capable of maintaining optimal humidity at the wound site while removing excess exudate, be particle-free, non-toxic and non-allergenic, impermeable to bacteria, comfortable and conformable, require reduced dressing changes, be cost effective and have long shelf life (Boateng and Catanzano, 2015; Boateng et al., 2008; Vowden and Vowden, 2017) . However, an optimal treatment should be chosen based on the wound conditions, location and considering the specific patient's needs (King et al., 2017) . Although βG is commercially available in the form of a hydrogel, we aimed to develop alternative βG-loaded wound dressing which would overcome the hydrogel-related limitations, i.e. limited use in treatment of exuding wounds.
Electrospinning is a versatile manufacturing method that forms nanofibrous dressings characterized by high surface area to volume ratio. Electrospinning opens new possibilities, as nanofibers can be designed to obtain a controlled and sustained release of active ingredients into the wound, by making appropriate choices regarding the processing method, copolymers applied and also embedding nanocarriers in to the nanofibers (Mei et al., 2016; Thakkar and Misra, 2017) . In addition, nanofiber mats are able to absorb wound exudate and provide a moist environment within the wound area. Moreover, the method is also suitable for forming nanofibers with active ingredients Fig. 1 . The in situ formed hydrogel (upon administration of nanofiber onto the wound) before covering with the polyurethane occlusive film.
that might accelerate wound healing (Liu et al., 2017; Mei et al., 2017; Wang et al., 2015) . Recently, the concept of novel functional wound dressing with real time monitoring of wound's pH and temperature by embedding biosensors within the dressing has been introduced (Salvo et al., 2017) .
Although the ability of yeast βG to promote wound healing was first reported already in 1980 (Leibovich and Danon, 1980) , and βG have been used in cosmetics and health promoting products for decades (Du et al., 2014) , nanofiberous wound dressings containing βG is still not available on the market. As discussed in the Introduction, the limited numbers of studies published on electrospun βG (Basha et al., 2017; Kawahara, 2014; Kim et al., 2012; Woo et al., 2010) , provide very scarce in vivo evidence mandatory for preclinical research. Thus, we were encouraged to develop electrospun nanofibers containing βG as the active ingredient. Based on the preliminary results obtained with the needle electrospinning setup (results not shown), PEO and HPMC were selected as copolymers for the βG-nanofibers, and the only polymers in the NoβG-nanofibers. To further optimize the formulation and to address potential upscaling of the production applying the Nanospider™ technology, we first optimized the spinning solutions.
3.1. Optimization of electrospinning and resulting nanofibers 3.1.1. The polymer solutions and viscosity characteristics
The properties of the polymer solution are one of the main factors affecting the transformation of the polymer solution into nanofibers by electrospinning (Son et al., 2004) . All polymers applied in the formulation, namely HPMC; PEO and βG, are water soluble. HPMC is a highly appreciated amorphous-state stabilizing carrier polymer in nanofibers (Paaver et al., 2015) . PEO is known to greatly improve the spinability of HPMC even at small concentrations (< 0.1%) (Balogh et al., 2016) , and is an easily electrospinnable polymer, widely applied as a co-spinning agent (Pakravan et al., 2011) . Although the preliminary studies showed that βG, in combination with HPMC and PEO, could be successfully electrospun from an aqueous solution, applying EtOH as a (co-)solvent made the polymer solutions less viscous and reduced the surface tension as compared to the pure aqueous solution (results not shown). Since the EtOH/water solvent system is environmentally acceptable, affordable and acceptable from the industrial point of view, this solvent system was preferred for the polymer solutions applied in the Nanospider™. Higher EtOH concentrations enabled the use of higher polymer concentrations in the βG-Sol and NoβG-Sol, as compared to the concentrations in the Ref-Sols (Table 1) ; the polymer concentrations were higher than reported by Frenot et al. (2007) who applied a 1:1 EtOH/water (v/v) solvent system for spinning HPMC in the needle electrospinning setup. Thus, a polymer concentration higher than 3% was applied in both βG-Sol and NoβG-Sol. The HPMC2 (Ref-Sol2) was more viscous as compared to HPMC1 (RefSol1), therefore the upper limit of recommendable viscosity regarding the spinability was exceeded when Ref-Sol2 was tested in the Nanospider™. The lack of nanofiber formation is usually attributed to too viscous polymer solution used in spinning; too viscous solutions limit the formation of jets (Bhardwaj and Kundu, 2010) . Thus, the Ref-Sol 3 was prepared with a 25% reduction in HPMC2 concentration as compared to Ref-Sol2, and had a final HPMC content of 2.14%. Different degree of substitution is known to affect the HPMC features (Nyamweya and Hoag, 2000) , and explains the different viscosities of two HPMCderivatives tested. As we aimed to reach higher polymer concentrations, the HPMC1 was chosen for the βG-Sol and NoβG-Sol.
The lower viscosity of NoβG-Sol as compared to βG-Sol (Fig. 2) , does not only relate to the absence of βG in the NoβG-Sol, but also to the lower volume of water, since the hydrophilic polymers swell less in EtOH compared to water. It is known that the length of the polymers greatly influences the viscosity of the spinning solution, therefore the polymers with smaller molecule weights could potentially have been used to gain higher polymer concentrations (Gupta et al., 2005) .
However, an increase in polymer length induces polymer entanglement and prevents the formation of beads on the nanofibers and helps the formation of continuous nanofibers (Bhardwaj and Kundu, 2010) . Thus, HPMC with lower molecule masses were not pursued. Spinning of both Ref-Sol1 and Ref-Sol3 resulted in nanofibers, however Ref-Sol1 formed only a very thin nanofiber layer on the substrate. Moreover, the layer was harder to peel off from the substrate than the other formulations.
Nanofiber production by needle-free electrospinning
To successfully produce electrospun nanofibers, not only the choice of polymer solutions, but also the processing parameters have to be optimal and controlled (Pelipenko et al., 2015) . Foremost, it is important to consider the characteristics of the equipment that will be used in manufacturing (Nayak et al., 2012) . Electrospinning has the advantage of producing the fibers in the nano-range, however comparing to other fiber producing methods, such as melt-blown, the production speed is rather slow (Persano et al., 2013) . By using needle-free electrospinning it is possible to produce higher volume of nanofiber sheets than with a traditional needle electrospinning setup (El-Newehy et al., 2011; Grothe et al., 2017; Nayak et al., 2012) . The advantage of needle-free electrospinning is that there are no needles, nozzles or spinnerets that can be clogged, making the Nanospider™ technology a good candidate for industrial upscaling and the chosen technology for this study. Using the Elmarco Nanospider™ Lab, a pilot scale machine, the following parameters were successfully applied: the highest current of 80 kV, a spinning distance of 20 cm and the maximum carriage movement speed of 300 mm/s. To obtain different thicknesses of the final nanofiber webs, the speed of the substrate was varied between 2 and 4 mm/min. When applying the Nanospider™ Lab machine, it is important to coat the spinning wire sufficiently to continuously produce Taylor cones (liquid meniscuses from where the charged fluid jets are ejected) all along the wire. When the nanofiber mats were prepared using the substrate speed of 2 mm/min, the feed rate limitation was related to the higher viscosity of Ref-Sol1, and the spinning wire did not receive the needed amount of spinning solution to produce a steady stream of Taylor cones. With a pump modification on the Nanospider™ Lab feed system, it could be possible to feed the spinning wire more efficiently to increase the output, since the solutions exhibit shear thinning (Fig. 2) . βG-Sol performed similarly to Ref-Sol3, producing a steady stream of Taylor cones along the spinning wire of the Nanospider™ Lab. The viscosity of the βG-Sol was close to the upper limit of what the Nanospider™ Lab can electrospin, and the solution contained the maximal dry content that the machine can handle within the current setup. The dry content in the NoβG-Sol could have been increased, without exceeding the viscosity limitation of the solution. However, since the dry content was in the same magnitude, the production speed was sufficient for both fibers, and the 40 mL batch volume was prepared within 30 min, and found to be suitable. Since the relative humidity affects the properties of the formed nanofibers to a high extent, and the higher humidity decreases the fiber diameter (Pelipenko et al., 2013b) , J. Grip et al. European Journal of Pharmaceutical Sciences 121 (2018) 269-280 the humidity and the temperature were monitored and controlled to be kept at 35 ± 2% and 26 ± 1°C, respectively.
Fourier-Transform Infrared Spectroscopy (FTIR) analysis
FTIR spectra for the dried raw materials and the final electrospun nanofibers (βG and NoβG) were recorded to confirm the presence of the respective polymers in the fibrous network comprising PEO (13.3%, w/ w) and HPMC (86.7%, w/w) in the NoβG-nanofibers, and PEO (10.0%, w/w), HPMC (65.4%, w/w) and βG (24.6%, w/w) in the βG-nanofibers, respectively. Although distinctive band positions might allow the identification of polysaccharide structures and their composition (Kacȗráková et al., 2000) , the interactions between the polymers, resulting in shifts in the band positions, as well as the overlapping bands originating from the different polymers in the sample, limit the interpretation of the spectra in terms of identifying the small spectral shifts of individual components in the mixture. However, the FTIR spectra obtained from the electrospun nanofibers demonstrated spectral features similar to the spectra obtained from the respective ingredients (Fig. 3) , although changes in the relative intensities and peak positions were observed. Bands characteristic for βG and HPMC in the region between 3600 and 3000 cm −1 , assigned to the eOH stretching from intermolecular-and intramolecular hydrogen bonds, were observed for all βG-and HPMC containing materials, whereas the CH-stretching band in the area between 3000 and 2200 cm , was observed in all spectra. The βG and HPMC exhibited, due to similar chemical structure, a more overlapping spectra than the PEO polymer. The CH 2 assigned peaks at 842, 960, 1240 and 1278 cm −1 from PEO were more pronounced in spectra of the NoβG fibers than the βG fiber spectra. The bands detected at around 1100 cm
, that are formed through the combination of the ether and methylene group stretching vibrations in PEO and indicated as CeOeC (Pucić and Jurkin, 2012) , were also more visible in the NoβG than βG fiber spectra. Thus, the intensity of these bands correlated to the PEO concentration in the nanofiber formulation.
Morphology of nanofibers
The morphology and dimensions of electrospun nanofibers provide a good indication of the quality of electrospinning, including the choice of polymers, their concentrations, choice of solvents, the machine and applied settings, as well as environmental settings (temperature and humidity).
The FE-SEM pictures of the electrospun nanofibers confirmed the fiber formation. The diameter of the electrospun nanofibers was 110 ± 74 nm and 180 ± 95 nm for nanofibers made from βG-Sol (Fig. 4A) and NoβG-Sol (Fig. 4B) , and 100 ± 50 nm and 81 ± 39 nm for nanofibers made from Ref-Sol 1 (Fig. 4C) and Ref-Sol 3 (Fig. 4D) , respectively. The increased diameter observed with increasing polymer concentrations (given in Table 1 ), is in accordance with reports from previous studies (Pelipenko et al., 2013b (Pelipenko et al., , 2015 . All nanofibers displayed the same structural forms, namely the ribbon shaped fibers. The formation of ribbon shaped/branched fibers might be due to the rapid evaporation of solvent from the outer part of the jet, and the subsequent diffusion of solvent from the core out through the surface of the fiber on the collector (Guenthner et al., 2006) . Changing the relative humidity could prevent the formation of ribbon shaped nanofibers and stabilize the jet (Pelipenko et al., 2013b) . However, the production of less branched fibers does not necessarily support a more effective cell mobility and three-dimensional cell migration in wound healing (Pelipenko et al., 2013a) , especially considering the rapid gelling of the nanofibers in this study (results given in Section 3.1.5). In addition, the relatively low humidity applied in this study (35 ± 2%) has been shown to lead to ticker nanofibers with a more homogeneous size distribution, and to decrease the beads formation, that might be a problem under the conditions of higher humidity and polymer concentrations, as well as with a long distance to the collector (Pelipenko et al., 2013b) .
The nanofiber swelling capacity
The dry nanofiber dressing is supposed to be applied directly onto the high to moderately exudation wound, and to absorb and retain the exudate onto the wound by forming an in situ gel (Fig. 1) that allows autolytic debridement, while promoting a successful wound healing environment. The capability of swelling is therefore crucial for the optimal therapy and was thus investigated.
The βG-nanofiber had a swelling index (I s ) of 1287 ± 109 and the NoβG-nanofiber of 1537 ± 141% (w/w), respectively. Similar level of swelling capacity was reported for alginate dressing, that can absorb up to 20 times their own weight in fluid (Vowden and Vowden, 2017) . The average weight of the βG-nanofibers and NoβG-nanofibers before swelling was 134 mg and 190 mg, respectively. There was no significant Fig. 3 . FTIR spectra of electrospun nanofibers (βG-and NoβG) and the corresponding polymers βG, HPMC and PEO. differences in the swelling index for the two fiber formulations. Although both fibers hydrated very rapidly, the βG-nanofiber seemed to hydrate somewhat slower than the NoβG-nanofiber. During the swelling, the βG-nanofiber retained air trapped under the fiber (Sup. Fig. 1B) , whereas the NoβG-nanofiber (Sup. Fig. 1C ) retained air within the gel. This might indicate that the βG-nanofiber would have retained more liquid if allowed to soak in the aqueous media for a longer time. However, both formulations were allowed to soak for only 60 s to avoid obtaining too liquefied fibers that would be impossible to remove from the Petri dish, and to allow excess aqueous media to be removed in a reproducible way. Thus, the relatively high swelling capacity clearly makes the nanofibers less mechanically stable. For comparison, the Curdlan/PVA nanofibers obtained for nanofiber scaffolds made for tissue engineering (Basha et al., 2017) , reached a swelling saturation of approximately 170% after 24 h swelling in PBS at 37°C.
The lower mechanical strength and fast swelling of our fibers can be contributed to the use of biodegradable and bioabsorbable polymers selected. The high swelling capacity and rather poor mechanical strength of this novel dressing indicate that it does not have to be removed from the wound; something that is highly advantageous considering patient comfort and pain associated to dressing exchange (Woo et al., 2008) . Moreover, since it is a transparent dressing, the wound healing progression and tissue can be observed although the wound is covered with the dressing.
Cytotoxicity of electrospun nanofibers
The toxicity of the nanofibers was tested in vitro using MTT assay method. Three different concentrations of the βG-nanofibers, NoβG-nanofibers and βG 2.5% (1, 10, 100 μg/mL) were applied on the keratinocytes. Neither the βG-nanofibers nor the NoβG-nanofibers and βG 2.5%, exhibited any toxicity up to the concentration of 100 μg/mL, which is in agreement with Choromanska et al. (2017) . These results suggest that nanofibers will not affect the cell viability during the proliferation phase of wound healing (Fig. 5) .
In vivo wound healing in diabetic mice
In the final stage of this study, the wound healing potential of the novel nanofibers, both with βG (βG-nanofibers) and without βG (NoβG-nanofibers) was tested in vivo. Three different doses of βG-nanofibers containing 190, 370 and 990 μg of βG (Table 1) , respectively, and the NoβG-nanofiber were administered onto the excisional wounds in the diabetic db/db mice. The changes in the wounds over time were evaluated using the Image Pro Plus software, that determined the wound contraction area and re-epithelization area (combined results given in Fig. 6 ) and open wound area (results given in Fig. 7) . Representative photographs from all treatment groups are provided in Sup. Fig. 3 . The histological evaluation of the wound tissue from mice receiving different treatments were made on day 24. Sup. Fig. 4 , showing representative H&M stained tissue sections from two different treatment groups; LowβG and NoβG, indicates the approach used in the evaluation. Photographs of a H&E stained tissue section from all six treatments groups, including positive and negative controls, are provided in Fig. 8 , whereas the results from picrosirius red straining of collagen within wounds treated with LowβG and NoβG are given in Fig. 9 . The diabetic db/db wound healing model is known to provide a well-defined wound bed that heals both from contraction and re-epithelialization, and is considered a reproducible and valuable model for testing experimental wound healing treatments . During the treatment, no adverse reactions were observed in any animal group. Only one animal in the LowβG group was removed due to subcutaneous abscess and rapid weight loss. However, these changes did not appear to be directly related to the treatment. All treatments were applied under occlusive cover, to retain the formulations in place, prevent moisture loss, and the animals from removing the treatment. The use of occlusive dressing is the current state-of-the-art as it is used in clinical wound care to prevent moisture loss and accelerate healing in the acute, chronic and infected wounds (Vowden and Vowden, 2017) . The use of occlusive dressing assists wound healing (Hinman and Maibach, 1963) . Although the occlusion in itself improve wound healing, the animals in the negative control group (water treatments) exhibited an increase in wounded area on day 4 (103.1% of initial wound). However, on day 8 the wound closure was in the same magnitude (25.8% of initial wound area) comparing to the NoβG group (26.5% of initial wound area) (Fig. 6) . After day 8, all nanofiber treatments were significantly better than the negative control and provided improved healing conditions (p < 0.05) (Fig. 7) . Thus, HPMC and PEO applied as copolymers in the nanofibers seem to contribute in providing an optimal moist environment for wound healing. The wound healing mechanisms of βG is derived from the activation of the macrophages and the subsequent signaling Ma and Underhill, 2013) , however, the results indicate that this healing potential is enhanced by the nanofibers (Figs. 6 and 7) .
All three groups treated with βG-nanofibers exhibited significantly improved wound closure (p < 0.05) as compared to the NoβG group (Fig. 7) . This finding was supported by the histology assessments made on day 24 (Fig. 8), showing that that the level of wound healing progression observed in response to the three βG containing nanofiber dressings was very similar to that following positive control treatment, and noticeably greater than both the negative control-treatment and NoβG nanofiber dressing. The results shown in Figs. 6 and 7 also demonstrate that the wound closure started faster during the βG- nanofiber treatment (76.8-82.3%) than the positive control (97.9%) on day 4; however on day 8 the wound closure in βG treated groups was similar to the wound closure in mice treated with positive control. Unfortunately, we could not confirm the dose-response for the βG-nanofibers, most probably because the effective dose was reached already with the lowest dose applied. Thus, it would be interesting to investigate the wound healing at lower βG dosages. This could be achieved either by lowering the concentration of βG in the electrospun nanofibers, the amount of nanofibers, or by reducing the frequency of dosing/application onto the wound. Lower doses or reduced frequency of treatment would have both economic benefits and be advantageous for the patient compliance and effect of the treatment. The less frequent treatment applied in the nanofiber groups might also have caused less stress to the mice and positively attribute to the healing process. It is known that the stress can inhibit wound healing in animals trough affecting the functional wound healing pathways (de Almeida et al.,
2016).
The wound healing potential of tested treatments was reproducibly demonstrated through the small standard deviations from the mean value of the assessed wound closure, contraction and re-epithelization (Fig. 6 ). All treated groups had a standard error mean (SEM) < 3.7, with an exception of the NoβG group (SEM of 8.9) in the wound closure assessment. The NoβG (βG-free nanofibers) are not expected to improve wound healing to a greater extent. In our previous study (Grip et al., 2017) we confirmed the healing potential of βG in wound healing, and present results additionally confirm the positive effects of βG in formulation. The improved wound healing in the βG-nanofiber treated groups as compared to the NoβG-nanofiber group seem to be attributed to the increased wound contraction rather than to an increase in the reepithelization, as evident on photographs (Fig. 7) . The wound healing contraction, attributed to the panniculus carnosus muscle, is known to be more pronounced in murine than in human . Due to the rapid gelling of the components within the nanofiber dressing, it is likely that the effects are not due to mechanistic contraction, but rater elicited by a cellular response to βG. When accounting for the re-epithelization in the diabetic db/db mice model, the contraction of the skin will mask some of re-epithelized tissue due to compaction of the wound (Wong et al., 2011) , leading to a decline in the cumulative granulation. This decline in re-epithelization can be seen in all groups with exception of the water-treated (negative control) group (Fig. 6) . However, considering the results obtained from the histological examination (Figs. 8 and 9 ), a marginally greater granulation tissue depth was observed following LowβG nanofiber treatment, than observed in response to both the MediumβG and HighβG nanofiber dressings, and positive control treatment. A similar trend was observed when collagen deposition was evaluated; with the greatest intensity of collagen staining observed for the LowβG nanofiber treatment. When wounds from the different βG treatment groups were compared histologically in terms of re-epithelialization, complete re-epithelialization was observed in response to LowβG nanofiber treatment; approx. 50% re-epithelialization was seen in response to MediumβG nanofiber and approx. 80% re-epithelialization was recorded following treatment with HighβG nanofiber dressing.
In our previous study on wound healing potential of βG formulated as hydrogel, we failed to prove its superiority as wound dressing. We suggested that the failure can be due to an adverse effect of Carbopol 971P NF in the hydrogel formulation (Grip et al., 2017) . The current in vivo results support the suggested explanation. In the present study, the excipients applied in the nanofibers seem not to interfere with the healing potential of βG. However, since the wound healing progression in wound tissue in mice treated with NoβG nanofiber dressing was found to be similar to that obtained in the control (water for injection) treatment group, displaying a very limited granulation tissue development and re-epithelization and consequently a minimal collagen deposition (Figs. 8 and 9) , most of the healing progression observed with the βG-containing nanofibers should be attributed to the active ingredient βG, and not the nanofiber structure.
There are several publications reporting the use of nanofibers for wound treatment in mice (Choi et al., 2008; Kim and Yoo, 2010; and rats (Dong et al., 2016; Mohammadi et al., 2016; Naseri-Nosar et al., 2017; Ramanathan et al., 2017) ; however, to the best of our knowledge this is the first work on in vivo wound healing of a in situ gel forming βG-nanofibers, with βG isolated from beakers yeast. There is only one in vivo study published on electrospun βG; the copolymer poly(lactic-co-glycolic acid) (PLGA) was used as vehicle for the βG isolated from Aureobasidium pullulans in nanofibers manufacturing (Kim et al., 2012) . Kim and co-authors observed small differences between the treatment with βG-containing nanofibers and PLGA alone. However, they found that βG stimulated the cells that helped with reepithelialization, proliferation and angiogenesis. The use of PLGA as a carrier provides a more rigid nanofiber structure that is less prone to lose its integrity, since PLGA degrades by hydrolysis and does not gel, contrary to PEO and HPMC used in our study. Considering that the structure of βG is crucial for the cellular response, and plays a significant role in the bioactivity of βG, these two studies are not directly comparable. In addition, the evidence of the wound healing potential of βG from Aureobasidium pullulans is rather limited (Du et al., 2014; Noss et al., 2013) .
The novel βG-containing nanofibers bear the potential to serve as an advanced wound dressing for exuding wounds. The manufacturing scale up should not present serious challenge within industrial manufacturing.
Conclusions
The Nanospider™ technology applied in the production of electrospun βG-nanofibers was proven to be a reproducible and reliable method to manufacture nanofibers of desired features considering the treatment of medium exuding wounds. Due to the high capacity of water retention and rapid swelling, the nanofibers formed a hydrogel in situ upon administration onto the wound. The novel formulation exhibited no cellular toxicity in the in vitro MTT assay. The wound healing assessment in the wound model of hard-to-heal wounds confirmed that the βG-nanofiber significantly improved the healing as compared to the NoβG-nanofibers. The findings can be applied as a ground for further testing in human. Yorkshire, England) and Dr. Jeff Hart, Managing Director and Dr. Andrea Bell, Principal Scientist, for support with the in vivo work. We would also like to acknowledge Dr. Ivo Laidmäe and Professor Jyrki T. Heinämäki for introducing us to electrospinning at the Department of Pharmacy, University of Tartu, Estonia.
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